Sartorius Stedim Biotech (GB:0RG8)
LSE:0RG8
Holding GB:0RG8?
Track your performance easily

Sartorius Stedim Biotech (0RG8) Financial Statements

2 Followers

Sartorius Stedim Biotech Financial Overview

Sartorius Stedim Biotech's market cap is currently ―. The company's EPS TTM is €1.779; its P/E ratio is 102.85; and it has a dividend yield of 0.39%. Sartorius Stedim Biotech is scheduled to report earnings on October 17, 2024, and the estimated EPS forecast is €0.86. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue€ 890.00M€ 878.40M€ 861.80M€ 862.50M€ 778.18M
Gross Profit€ 473.10M€ 461.00M€ 445.90M€ 454.50M€ 407.20M
EBIT€ 216.20M€ 289.50M€ 294.50M€ 348.80M€ -2.38M
EBITDA€ 272.30M€ 331.70M€ 337.20M€ 389.50M€ 33.47M
Net Income Common Stockholders€ 186.70M€ 204.50M€ 214.80M€ 270.10M€ 8.21M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 133.00M€ 161.70M€ 181.00M€ 212.20M€ 237.35M
Total Assets€ 5.07B€ 5.10B€ 4.38B€ 4.16B€ 3.95B
Total Debt€ 1.14B€ 1.17B€ 732.20M€ 630.90M€ 625.52M
Net Debt€ 1.00B€ 1.00B€ 551.20M€ 418.70M€ 388.17M
Total Liabilities-€ 2.75B€ 2.25B€ 2.16B€ 2.22B
Stockholders Equity€ 2.45B€ 2.27B€ 2.05B€ 1.92B€ 1.66B
Cash Flow-
Free Cash Flow€ 77.70M€ 36.60M€ -24.60M€ 92.00M€ 348.37M
Operating Cash Flow€ 219.60M€ 145.40M€ 78.10M€ 169.20M€ 162.37M
Investing Cash Flow€ -148.00M€ -584.60M€ -103.90M€ -121.00M€ -140.23M
Financing Cash Flow€ -105.60M€ 424.00M€ 9.80M€ -107.50M€ -30.71M
Currency in EUR

Sartorius Stedim Biotech Earnings and Revenue History

Sartorius Stedim Biotech Debt to Assets

Sartorius Stedim Biotech Cash Flow

Sartorius Stedim Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis